Overexpression of Pygopus2 protects HeLa cells from vinblastine-induced apoptosis

Biological Chemistry

Volumn 390, Issue 2, 2009, Pages 157-165

  De, Degejing ^a   Chen, Apeng ^a   Wu, Zhiqiang ^a   Lv, Songya ^a   He, Guoqing ^a   Qi, Yipeng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

AP 1; Bcl 2; JNK; Phosphorylation; Wnt signaling

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 9; PROTEIN BCL 3; PYGOPUS 2; UNCLASSIFIED DRUG; VINBLASTINE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL LINE; CELL PROTECTION; DNA FRAGMENTATION; DRUG INHIBITION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; GENE DELETION; GENE EXPRESSION; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VINBLASTINE;

PYGOPUS;

EID: 59949098595     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.014     Document Type: Article

References (36)

1. Andrews, P.G., Lake, B.B., Popadiuk, C., and Kao, K.R. (2007). Requirement of Pygopus 2 in breast cancer. Int. J. Oncol. 30, 357-363.
2. Belenkaya, T.Y., Han, C., Standley, H.J., Lin, X., Houston, D.W., Heasman, J., and Lin, X. (2002). Pygopus encodes a nuclear protein essential for wingless/Wnt signaling. Development 129, 4089-4101.
3. Cadigan, K.M. (2002). Wnt signaling - 20 years and counting. Trends Genet. 18, 340-342.
4. Chen, S., Guttridge, D.C., You, Z., Zhang, Z., Fribley, A., Mayo, M.W., Kitajewski, J., and Wang, C.Y. (2001). Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J. Cell Biol. 152, 87-96.
5. de la Roche, M. and Bienz, M. (2007). Wingless-independent association of Pygopus with dTCF target genes. Curr. Biol. 17, 556-561.
6. Fan, M., Goodwin, M., Vu, T., Brantley-Finley, C., Gaarde, W.A., and Chambers, T.C. (2000). Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J. Biol. Chem. 275, 29980-29985.
7. 2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine. Cancer Res. 61, 4450-4458.
8. Jordan, A., Hadfield, J.A., Lawrence, N.J., and McGown, A.T. (1998). Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 18, 259-296.
9. Katoh, M. and Katoh, M. (2007). WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13, 4042-4045.
10. Klein, P.S. and Melton, D.A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459.
11. Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone, M., Zullig, S., and Basler, K. (2002). Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell 109, 47-60.
12. Lake, B.B. and Kao, K.R. (2003). Pygopus is required for embryonic brain patterning in Xenopus. Dev. Biol. 261, 132-148.
13. Lin, A. (2003). Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25, 17-24.
14. Ling, Y.H., Tornos, C., and Perez-Soler, R. (1998). Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J. Biol. Chem. 273, 18984-18991.
15. Martin, S.J., Lennon, S.V., Bonham, A.M., and Cotter, T.G. (1990). Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145, 1859-1867.
16. McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J., and Lowe, S.W. (1997). bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 94, 2345-2349.
17. Mosimann, C., Hausmann, G., and Basler, K. (2006). Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with β-catenin/Armadillo. Cell 125, 327-341.
18. Muller, I.M., Dirsch, V.M., Rudy, A., Lopez-Anton, N., Pettit, G.R., and Vollmar, A.M. (2005). Cephalostatin 1 inactivates Bcl-2 by hyperphosphorylation independent of M-phase arrest and DNA damage. Mol. Pharmacol. 67, 1684-1689.
19. 2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J. Biol. Chem. 271, 30950-30955.
20. Parker, D.S., Jemison, J., and Cadigan, K.M. (2002). Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development 129, 2565-2576.
21. Pathan, N., Aime-Sempe, C., Kitada, S., Haldar, S., and Reed, J.C. (2001). Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. Neoplasia 3, 70-79.
22. Popadiuk, C.M., Xiong, J., Wells, M.G., Andrews, P.G., Dankwa, K., Hirasawa, K., Lake, B.B., and Kao, K.R. (2006). Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer. Clin. Cancer Res. 12, 2216-2223.
23. Reed, J.C. (1999). Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17, 2941-2953.
24. Ruvolo, P.P., Deng, X., and May, W.S. (2001). Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15, 515-522.
25. Schwab, K.R., Patterson, L.T., Hartman, H.A., Song, N., Lang, R.A., Lin, X., and Potter, S.S. (2007). Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. BMC Biol. 5, 15.
26. 11C]Vinblastine syntheses and preliminary imaging in cancer patients. J. Pharm. Pharm. Sci. 10, 266s-276s.
27. Song, N., Schwab, K.R., Patterson, L.T., Yamaguchi, T., Lin, X., Potter, S.S., and Lang, R.A. (2007). Pygopus 2 has a crucial, Wnt pathway-independent function in lens induction. Development 134, 1873-1885.
28. Stone, A.A. and Chambers, T.C. (2000). Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res. 254, 110-119.
29. Thompson, B., Townsley, F., Rosin-Arbesfeld, R., Musisi, H., and Bienz, M. (2002). A new nuclear component of the Wnt signalling pathway. Nat. Cell Biol. 4, 367-373.
30. Townsley, F.M., Cliffe, A., and Bienz, M. (2004). Pygopus and Legless target Armadillo/β-catenin to the nucleus to enable its transcriptional co-activator function. Nat. Cell Biol. 6, 626-633.
31. Ueda, Y., Hijikata, M., Takagi, S., Takada, R., Takada, S., Chiba, T., and Shimotohno, K. (2002). Wnt/β-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int. J. Cancer 99, 681-688.
32. Vantieghem, A., Xu, Y., Assefa, Z., Piette, J., Vandenheede, J.R., Merlevede, W., De Witte, P.A., and Agostinis, P. (2002). Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J. Biol. Chem. 277, 37718-37731.
33. Wang, T.H., Wang, H.S., Ichijo, H., Giannakakou, P., Foster, J.S., Fojo, T., and Wimalasena, J. (1998). Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273, 4928-4936.
34. 2/M. Mol. Cell. Biol. 19, 8469-8478.
35. Yang, F., Zeng, Q., Yu, G., Li, S., and Wang, C.Y. (2006). Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell. Signal. 18, 679-687.
36. You, Z., Saims, D., Chen, S., Zhang, Z., Guttridge, D.C., Guan, K.L., MacDougald, O.A., Brown, A.M., Evan, G., Kitajewski, J., et al. (2002). Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell Biol. 157, 429-440.